×
About 1,964 results

ALLMedicine™ Cerebral Venous Thrombosis Center

Research & Reviews  947 results

Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic rev...
https://doi.org/10.1136/bmjopen-2020-040212
BMJ Open; Bose G, Graveline J et. al.

Feb 17th, 2021 - Current guidelines do not recommend direct oral anticoagulants (DOACs) to treat cerebral venous thrombosis (CVT) despite their benefits over standard therapy. We performed a systematic review to summarise the published experience of DOAC therapy i...

Rivaroxaban for the treatment of cerebral venous thrombosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883416
BMC Neurology; Esmaeili S, Abolmaali M et. al.

Feb 16th, 2021 - New Oral Anticoagulants (NOACs) such as Rivaroxaban are introduced as alternatives to conventional vitamin-K antagonists in the long-term treatment of thrombotic events due to their lower bleeding risk. There is a lack of evidence on the effective...

Asymmetric pathological pachymeningeal enhancement: A new imaging feature for cerebral ...
https://doi.org/10.1016/j.clineuro.2021.106516
Clinical Neurology and Neurosurgery; Liu Y, Zhang C et. al.

Feb 6th, 2021 - Cerebral venous thrombosis (CVT) has various clinical presentations and has a median onset delay of 7 days. So it is important to find more identifiable early imaging manifestations for CVT. This was a retrospective study. Patients with CVT (CVT g...

A rare complication of cerebral venous thrombosis during simple percutaneous coronary i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850649
Medicine Lo MY, Chen MS et. al.

Feb 3rd, 2021 - Cerebrovascular accidents (CVAs) after percutaneous coronary intervention (PCI), although rare, are associated with high in-hospital morbidity and mortality rates. Cerebral venous thrombosis (CVT) is an uncommon cause of CVAs compared with arteria...

Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infectio...
https://doi.org/10.1111/ene.14727
European Journal of Neurology; Baldini T, Asioli GM et. al.

Jan 11th, 2021 - Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection predisposes patients to arterial and venous thrombosis. This study aimed to systematically review the available evidence in the literature for cerebral venous thrombosis (CVT) ...

see more →

Guidelines  3 results

European Stroke Organization guideline for the diagnosis and treatment of cerebral veno...
https://doi.org/10.1111/ene.13381
European Journal of Neurology; Ferro JM, Bousser MG et. al.

Aug 23rd, 2017 - Current guidelines on cerebral venous thrombosis (CVT) diagnosis and management were issued by the European Federation of Neurological Societies in 2010. We aimed to update the previous European Federation of Neurological Societies guidelines usin...

New guidelines for the management of cerebral venous thrombosis.
https://doi.org/10.1227/01.neu.0000400016.31648.3f
Neurosurgery Aoun SG, Rahme RJ et. al.

Jul 27th, 2011 - New guidelines for the management of cerebral venous thrombosis.|2011|Aoun SG,Rahme RJ,Batjer HH,Bendok BR,|therapeutic use,diagnosis,therapy,diagnosis,therapy,

Diagnosis and management of cerebral venous thrombosis: a statement for healthcare prof...
https://doi.org/10.1161/STR.0b013e31820a8364
Stroke Saposnik G, Barinagarrementeria F et. al.

Feb 4th, 2011 - The purpose of this statement is to provide an overview of cerebral venous sinus thrombosis and to provide recommendations for its diagnosis, management, and treatment. The intended audience is physicians and other healthcare providers who are res...

see more →

Clinicaltrials.gov  977 results

Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic rev...
https://doi.org/10.1136/bmjopen-2020-040212
BMJ Open; Bose G, Graveline J et. al.

Feb 17th, 2021 - Current guidelines do not recommend direct oral anticoagulants (DOACs) to treat cerebral venous thrombosis (CVT) despite their benefits over standard therapy. We performed a systematic review to summarise the published experience of DOAC therapy i...

Rivaroxaban for the treatment of cerebral venous thrombosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883416
BMC Neurology; Esmaeili S, Abolmaali M et. al.

Feb 16th, 2021 - New Oral Anticoagulants (NOACs) such as Rivaroxaban are introduced as alternatives to conventional vitamin-K antagonists in the long-term treatment of thrombotic events due to their lower bleeding risk. There is a lack of evidence on the effective...

Asymmetric pathological pachymeningeal enhancement: A new imaging feature for cerebral ...
https://doi.org/10.1016/j.clineuro.2021.106516
Clinical Neurology and Neurosurgery; Liu Y, Zhang C et. al.

Feb 6th, 2021 - Cerebral venous thrombosis (CVT) has various clinical presentations and has a median onset delay of 7 days. So it is important to find more identifiable early imaging manifestations for CVT. This was a retrospective study. Patients with CVT (CVT g...

A rare complication of cerebral venous thrombosis during simple percutaneous coronary i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850649
Medicine Lo MY, Chen MS et. al.

Feb 3rd, 2021 - Cerebrovascular accidents (CVAs) after percutaneous coronary intervention (PCI), although rare, are associated with high in-hospital morbidity and mortality rates. Cerebral venous thrombosis (CVT) is an uncommon cause of CVAs compared with arteria...

Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infectio...
https://doi.org/10.1111/ene.14727
European Journal of Neurology; Baldini T, Asioli GM et. al.

Jan 11th, 2021 - Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection predisposes patients to arterial and venous thrombosis. This study aimed to systematically review the available evidence in the literature for cerebral venous thrombosis (CVT) ...

see more →

News  37 results

CVT Incidence Three Times Higher Than Previously Reported
https://www.staging.medscape.com/viewarticle/936923

Sep 3rd, 2020 - The US incidence of cerebral venous thrombosis (CVT), an uncommon but important cause of stroke, is more than three times greater than previously reported, new research suggests. However, whether this is a real increase or simply an artifact of be...

CVT Incidence Three Times Higher Than Previously Reported
https://www.medscape.com/viewarticle/936923

Sep 3rd, 2020 - The US incidence of cerebral venous thrombosis (CVT), an uncommon but important cause of stroke, is more than three times greater than previously reported, new research suggests. However, whether this is a real increase or simply an artifact of be...

New European Guidelines for Cerebral Venous Thrombosis
https://www.staging.medscape.com/viewarticle/885729

Sep 14th, 2017 - New guidelines for the diagnosis and treatment of cerebral venous thrombosis (CVT) have been issued by the European Stroke Organisation. The guidelines, published in the European Journal of Neurology, have also been endorsed by the European Academ...

New European Guidelines for Cerebral Venous Thrombosis
https://www.medscape.com/viewarticle/885729

Sep 14th, 2017 - New guidelines for the diagnosis and treatment of cerebral venous thrombosis (CVT) have been issued by the European Stroke Organisation. The guidelines, published in the European Journal of Neurology, have also been endorsed by the European Academ...

Cerebral Venous Thrombosis
https://www.mdedge.com/fedprac/article/141901/dvt/vte/cerebral-venous-thrombosis/page/0/1

Jul 14th, 2017 - Given the variable and often nonspecific clinical presentations of these cases, unenhanced CT typically is the first imaging study ordered. According to the literature, noncontrast CT is not sensitive (25%-56%) in detecting CVT, and findings are n.

see more →